BOSTON (January 29, 2014) — Boston Children’s Hospital has licensed the rights to commercialize its T3 patient-monitoring technology to Etiometry Inc., a Boston-based health care information technology company creating predictive patient care analytics. The T3 Intensive Care Unit (ICU) software captures and visualizes patients’ physiologic data and tracks their clinical course. The technology provides a platform to track vital patient data on a single, easy-to-manipulate monitoring system viewable on standard web browsers in the hospital.
T3 (Tracking, Trajectory and Triggering) was the brainchild of Peter Laussen, MD, former chief of Boston Children’s Critical Care Unit and now chief of the Department of Critical Care Medicine at the Hospital for Sick Children, Toronto, and Melvin C. Almodovar, MD, medical director of Boston Children’s Cardiac Intensive Care Unit. The pair aimed to improve data management in the ICU, where providers need to manage data generated by 10 or more patient-monitoring devices. Laussen and Almodovar devised T3 to streamline and harness the massive volume of data generated by these systems.
“Access to the continuous data stream of relevant information has changed the way we track the evolution of a patient’s course as well as how we evaluate major events,” says Almodovar. “We are employing methods to analyze both the captured and real-time data for the purposes of developing and testing algorithms to guide our understanding of the patient’s physiological state and to support decision-making, in real time.”
While the system was originally built independently, over the past two years, Etiometry partnered with Boston Children’s researchers to refine the platform for delivering clinical analytics and patient risk monitoring. The result is a risk-based analytics solution that enables clinicians to easily track the real-time trajectories of their ICU patients through an intuitive web-based interface.
“The success of our co-development relationship proved Etiometry to be the ideal partner to commercialize this transformative technology,” says Erik Halvorsen, director of the Technology and Innovation Development Office at Boston Children’s. “T3 has the potential to revolutionize the delivery of ICU care.”
”We’re very excited about licensing the T3 technology and continuing our working relationship with Boston Children’s Hospital to develop cutting-edge clinical analytics to improve the quality and reduce the cost of patient care,” says Evan Butler, president of Etiometry.
The T3 patient-monitoring system and risk-based predictive analytics software have been deployed in two major pediatric centers: Boston Children’s and Toronto SickKids. Plans to install T3 in additional hospitals in the U.S. and Europe are underway. By presenting real-time, continuous physiologic information through a user interface, clinicians can now better discern a patient’s trajectory pattern to allow enhanced continuous assessment and anticipation of major events.
“The ICU is the most data intensive place in healthcare, yet most of this data is wastefully discarded,” says Dimitar Baronov, chief technology officer at Etiometry. “T3 will harness the power of this data for better care.”
Unlike previous generation patient-monitoring systems, which discard data after a few days, T3 includes a permanent data warehouse. Boston Children’s and Etiometry plan to create a consortium to provide and use stored data to develop predictive algorithms that can improve the quality of care and reduce costs in the ICU.
Boston Children’s Hospital is home to the world’s largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 13 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children’s research community. Founded as a 20-bed hospital for children, Boston Children’s today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children’s is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children’s, visit: http://vectorblog.org.
Etiometry Inc., headquartered in Boston, is a health care information technology (HIT) company creating Predictive Patient Care analytics to improve the quality of critical care. Its proprietary technology assists medical personnel by interpreting large volumes of real-time data and providing early identification of patient deterioration.
To learn more about Etiometry, visit their website at: www.etiometry.com
Boston Children's Hospital
Evan Butler, President